Font Size: a A A

Efficacy Analysis Of Nasal Bi-level Positive Airway Pressure Ventilation And Nasal Continuous Positive Airway Pressure Ventilation In The Treatment Of Neonatal Respiratory Distress Syndrome

Posted on:2020-06-10Degree:MasterType:Thesis
Country:ChinaCandidate:M L WangFull Text:PDF
GTID:2404330590982705Subject:Academy of Pediatrics
Abstract/Summary:PDF Full Text Request
Objectivecomparison of nasal bi-level positive airway pressure ventilation and nasal continuous positive airway pressure ventilation in the treatment of neonatal respiratory distress syndrome.MethodsA retrospective analysis was performed on 129 preterm infants with neonatal respiratory distress syndrome who were admitted to the neonatal intensive care unit of Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology between January,2017 and February,2019.According to the non-invasive respiratory support model,they were divided into NBiPAP group?n=68?and NCPAP group?n=61?.The general conditions,high risk factors,blood gas changes,inhaled oxygen concentration,invasive respiratory support time,non-invasive respiratory support time,total oxygen consumption time,hospital stay,and complications were compared between the two groups.ResultsThere were significant differences in PH,PCO2 and FiO2 of the two groups before and after treatment?P<0.05?.The PH at 6 and 12 hours and the PCO2 at 6 hours after treatment of NBiPAP group were better than those in NCPAP group,and the difference between the two groups was statistically significant?P<0.05?.The proportion of invasive respiratory support required in the NBiPAP group was lower than that in the NCPAP group,and the difference between the two groups was statistically significant?P<0.05?.There were no significant differences in the invasive respiratory support time,non-invasive respiratory support time,total oxygen consumption time,hospital stay and complications between the two groups?P>0.05?.ConclusionNBiPAP and NCPAP are effective in the treatment of neonatal respiratory distress syndrome.Compared with NCPAP,NBiPAP can reduce the invasive respiratory support rate without increasing the incidence of complications.
Keywords/Search Tags:Neonate, respiratory distress syndrome, nasal bi-level positive airway pressure ventilation, nasal continuous positive airway pressure, pulmonary surfactant
PDF Full Text Request
Related items
Clinical Research On Three Noninvasive Ventilation Strategies For The Treatment Of Neonatal Respiratory Distress Syndrome
Nasal Intermittent Positive Pressure Ventilation Versus Nasal Continuous Positive Airway Pressure For Neonatal Respiratory Distress Syndrome:a Randomized,Controlled, Prospective Study
A Prospective Rct:The Security And Efficacy Of Nasal Continuous Positive Airway Pressure(NCPAP) As Continuous Treatment After Synchronize Nasal Intermittent Positive Pressure Ventilation(SNIPPV) Of Premature Neonates With Respiratory Distress Syndrome AS
Efficacy And Safety Of Inhalation Of Pulmonary Surfactant Using Vibrating Mesh Nebulizers Combined With Nasal Continuous Positive Airway Pressure In The Treatment Of Neonatal Respiratory Distress Syndrome
Comparison Of Three Non-Invasive Ventilation Strategies For RDS As The Primary Therapy In Preterm Infants Born At Less Than 32 Weeks' Gestation
Application Of Two Kinds Of Non-invasive Positive Pressure Ventilation As A Mode Of Ventilation In Neonatal Respiratory Distress Syndrome:a Randomized Controlled Trial
A Study Of The Clinical Efficacy Of Nasal Intermittent Positive Pressure Ventilation In The Treatment Of Respiratory Distress Syndrome In Premature Infant
Three Non-invasive Ventilation Strategies For Preterm Infants With Respiratory Distress Syndrome:A Propensity Score Analysis
Research And Application Progress Of Nasal Intermittent Positive Pressure Ventilation In Preterm Respiratory Distress Syndrome
10 Discussion On The Mechanism Of Lung Injury Induced By Invasive Ventilator In Newborn Rats And Clinical Study On The Application Of Non-invasive Ventilator In Premature Infants With Respiratory Distress Syndrome